Sustainable Week: Fixing Our Broken Moral Compass
By Chuck Stern,
BTRtoday
| 07. 08. 2016
[citing CGS’ Elliot Hosman]
What if we could fix a broken moral compass? According to bioethicist and sociologist James J. Hughes of the Institute for Ethics and Emerging Technologies, we're already there.
In a provocative piece published in the Washington Post last month, Hughes cites dopamine-stimulating ADHD medications as current examples of "moral enhancement," and argues that other treatments like gene therapies and implants will soon follow, even if usage "will not be voluntary."
If this sounds unsettling, you are not alone. Elliot Hosman of the Center for Genetics and Society, who previously spoke to BTRtoday about this "socially dangerous" slope, weighs in on Hughes' claims.
Hosman believes that the field of behavioral genetics is fraught with biases, mishaps, and "conflicts of interest that warp the scientific process." They assert that Hughes' characterizations are "reductive" in the way that they misrepresent the nuances of the field; while Hughes believes that "criminality" and "sexual promiscuity" are genetically predetermined, Hosman insists that this is contradicted by both genetics and the social sciences. They further warn of "genetic determinism," the notion that there is "inherent value" in...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...